NYSE: BMY
Bristol Myers Squibb Co Earnings & Revenue

BMY past revenue growth

How has BMY's revenue growth performed historically?
Company
46.13%
Industry
6.62%
Market
16.55%
BMY's revenue has grown faster (16.30% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
BMY's revenue has grown faster (16.30% per year) than the US market average (15.67%)
Performance
BMY's revenue growth is accelerating - its growth over the last year (46.13%) is above its 5-year compound annual rate (16.30%)
Performance

BMY earnings and revenue history

Current Revenue
$34.9B
Current Earnings
-$563.0M
Current Profit Margin
-1.60%

BMY Return on equity

Current Company
-1.30%
Current Industry
10.90%
Current Market
-36.30%
BMY's Return on Equity (-1.30%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

BMY Return on assets

Current Company
-0.50%
Current Industry
8.50%
Current Market
6.20%
BMY is generating lower Return on Assets (-0.50%) than the US Drug Manufacturers - General industry average (8.27%)
Performance

BMY Return on capital employed

Current Company
2.41%
Current Industry
12.80%
BMY's ability to generate Return on Capital (2.41%) has decreased compared to 3 years ago (24.27%)
Performance

BMY earnings dates

Next earnings date
Nov 5, 2020

Bristol Myers Squibb Earnings & Revenue FAQ

On May 07, 2020, Bristol Myers Squibb (NYSE: BMY) reported Q1 2020 earnings per share (EPS) of -$0.34, up 132.38% year over year. Total Bristol Myers Squibb earnings for the quarter were -$775.00 million. In the same quarter last year, Bristol Myers Squibb's earnings per share (EPS) was $1.05.
On May 07, 2020, Bristol Myers Squibb (NYSE: BMY) reported Q1 2020 revenue of $10.78 billion up 82.11% year over year. In the same quarter last year, Bristol Myers Squibb's revenue was $5.92 billion.
As of Q4 2020, Bristol Myers Squibb's earnings has grown null year over year. Bristol Myers Squibb's earnings in the past year totalled -$563.00 million.
As of Q4 2020, Bristol Myers Squibb's revenue has grown 46.13% year over year. This is 39.51 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. Bristol Myers Squibb's revenue in the past year totalled $34.86 billion.
Bristol Myers Squibb's earnings date is Nov 05, 2020. Add BMY to your watchlist to be reminded of BMY's next earnings announcement.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics